SRSeyed Mahmoud Reza Hashemi Rafsanjani

Seyed Mahmoud Reza Hashemi Rafsanjani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Seyed Mahmoud Reza Hashemi Rafsanjani has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • The Association Between COVID-19 Vaccination Among Pregnant Women and Neonatal Outcomes: A Systematic Review and Meta-Analysis

    by Mohammad Darvishi, Majid Nouri, Mehdi Arzani, Seyyed Ziya Hejrypour, Seyed Mahmoud Reza Hashemi Rafsanjani

    Introduction: Limited data exist regarding the safety of COVID-19 vaccines during pregnancy. Despite some studies supporting vaccine safety and efficacy in pregnant women, hesitancy persists. Hence, this study aims to evaluate vaccination effects on pregnancy and neonatal outcomes in vaccinated pregnant women compared to unvaccinated controls. Methods: We conducted a comprehensive literature search in databases including PubMed, Web of Science, and Scopus without any time restrictions up to September 2023. We used specific Medical Subject Headings (MeSH) terms and keywords related to COVID-19, pregnancy, neonatal outcomes, and vaccination. Studies without control groups, lacking neonatal outcome data, or not in English were excluded. Data on preterm births, small for gestational age, NICU admissions, low APGAR scores, and low birth weights were extracted and analyzed using statistical methods to pool odds ratios and assess heterogeneity and publication bias. Results and Discussion: Finally, 27 studies were included in our final analysis. Vaccinated mothers exhibited a lower prevalence of preterm birth, with a pooled OR of 0.78 (95% CI: 0.70, 0.87, p-value < 0.01). No significant difference was found in the prevalence of SGA between the two groups, with a pooled OR of 0.99 (95% CI: 0.92, 1.07, p-value = 0.77). There was no significant difference in NICU admissions between the two groups, with a pooled OR of 0.89 (95% CI: 0.60, 1.32, p-value = 0.57). Conversely, unvaccinated mothers had a significantly higher prevalence of low 5-minute APGAR scores, with a pooled OR of 0.84 (95% CI: 0.72, 0.98, p-value = 0.02), and low birth weight, with a pooled OR of 0.83 (95% CI: 0.70, 0.97, p-value = 0.02). Conclusion: Our results demonstrated a significant decrease in the odds ratio of preterm birth, low birth weight, and low APGAR scores among those who received COVID-19 vaccination. However, we did not find a significant link between COVID-19 vaccination and the risk of NICU admission or the SGA.

  • Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta-Analysis and Systematic Review

    by Seyed Mahmood Reza Hashemi Rafsanjani, Rasoul Rahimi, Saeid Heidari-Soureshjani, Mohammad Darvishi, Omid-Ali Adeli, Saber Abbaszadeh

    Background: Hepatocellular Carcinoma (HCC) is a public health problem around the world. Several studies have investigated the association between statin use and the risk of HCC, however, more studies are needed in this field. Objectives: This systematic review and meta-analysis aimed to investigate the relationship between statin use and HCC risk. Methods: Systematic searches of Web of Science, Scopus, PubMed, Cochrane, Science Direct, and Embase were conducted for studies published between 1980 and September 2023. Metaanalyses were performed using Stata 15 with a significance level of 0.05. Results: The search retrieved 8,125 articles, of which 40 were included in the meta-analysis after applying eligibility criteria. The total sample was 5,732,948 participants, including 68,698 HCC cases. Statin use was associated with a 44% lower risk of HCC compared to non-use (RR 0.56, 95% CI 0.50–0.63, p < 0.001). The RR was 0.54 (0.42-0.69) in American countries, 0.52 (0.44-0.62) in Asian countries, and 0.63 (0.48-0.84) in European countries. The RR was 0.50 (0.42-0.60) in studies with a mean age <50 years and 0.61 (0.53-0.70) in studies with a mean age ≥50 years. No evidence of publication bias was found (Begg’s test p = 0.718). Conclusion: This meta-analysis found statin use is associated with a significantly lower HCC risk. Statins may be a promising preventive intervention against HCC


  • A Systematic Review of the Impact of Resveratrol on Viral Hepatitis and Chronic Viral Hepatitis-related Hepatocellular Carcinoma

    by Mohammad Darvishi, Majid Nouri, Rasoul Rahimi, Saeid Heidari-Soureshjani, Seyed Mahmoud Reza Hashemi Rafsanjani

    Background: Resveratrol (RSV) is used for the treatment of various diseases due to their anti-inflammatory and antioxidant activities. However, its beneficial aspects on viral hepatitis have been less investigated. Objective: This report reviews the impact of resveratrol on viral hepatitis and chronic viral hepatitis-related hepatocellular carcinoma (HCC). Methods: The systematic review was performed and reported according to the PRISMA 2020 statement. Several core databases, such as Cochrane Library, PubMed, Web of Science, EMBASE, and Scopus, were used for search on September 6, 2023. After extraction of the data, the desired information of the full text of the studies was recorded in Excel, and the outcomes and mechanisms were reviewed. Results: RSV inhibits viral replication through anti-HCV NS3 helicase activity, maintains redox homeostasis via glutathione (GSH) synthesis, improves T and B cell activity, and suppresses miR-155 expression. It also enhances viral replication by enhancing hepatitis C virus (HCV) RNA transcription, activating sirtuin-1 (SIRT1), which can increase peroxisome proliferator-activated receptor (PPAR), and SIRT1 activates the HBV X protein (HBx). Moreover, RSV is responsible for hepatitis-related HCC proliferation via suppression of mammalian target of rapamycin (mTOR), SIRT1 up-regulation, inhibiting expression of HBx, and reducing expression of cyclin D1. Conclusion: Despite the promising properties of RSV in inhibiting hepatitis-related HCC cell proliferation, its antiviral effects in viral hepatitis are controversial. The antihepatitis behaviors of RSV are mainly dose-dependent, and in some studies, activating some hepatoprotective pathways increases the transcription and replication of chronic HBV and HCV. Therefore, healthcare providers should be aware of viral hepatitis before using RSV supplements.


  • The Association between use of Renin-Angiotensin-Aldosterone System Inhibitors and the Risk and Mortality of Pancreatic Cancer: A Systematic Review and Meta-Analysis

    by Rasoul Rahimi, Seyed Mahmood Reza Hashemi Rafsanjani, Saeid Heidari-Soureshjani, Catherine Mary Turner Sherwin, Karamali Kasiri

    Background: Pancreatic Cancer (PC) is one of the most malignant tumors and highly invasive neoplasms around the world. Objective: This systematic review and meta-analysis aims to study the relationship between the use of renin-angiotensin-aldosterone system inhibitors and the incidence and mortality of PC. Methods: The electronic search was conducted systematically until October 10, 2023. in databases, including Scopus, Web of Science (WOS), PubMed/MEDLINE, Cochrane Library, and Embase. The required data were extracted from the articles and were analyzed by Stata 15 using statistical tests (Chi-square and I2), Forest plots, and publication bias tests (Begg's and Egger's tests). Results: A total of four studies (2011-2019; n=314,856) investigated the relationship between RAS antagonists and PC risk. No significant associations were found between angiotensin receptor blockers (ARBs) (OR=0.94, 95% CI: 0.77-1.14, p=0.513), angiotensin-converting enzyme inhibitors (ACEIs) (OR=0.96, 95% CI: 0.84-1.09, p=0.505), or combination therapy (ARBs + ACEIs) (OR=0.97, 95% CI: 0.87-1.09, p=0.627) and PC risk. Also, nine studies (2010-2023; n=20,483) examined the association between renin-angiotensin-aldosterone system inhibitors and PC mortality. Significant reductions in PC mortality were found for ARBs (OR=0.81, 95% CI: 0.66-0.98, p=0.032), ACEIs (OR=0.89, 95% CI: 0.80-0.99, p=0.038), and combination therapy (OR=0.83, 95% CI: 0.70-0.97, p=0.022). No evidence of publication bias was found in the study results. Conclusion: In summary, while renin-angiotensin-aldosterone system inhibitors did not appear to impact PC risk, their use was associated with lower PC mortality based on this meta-analysis of the current evidence. More rigorous and well-designed studies are required to validate and support these findings.


  • Biological Mechanisms of Polyphenols against Clostridium Difficile: A Systematic Review

    by Mohammad Darvishi, Seyed Mahmoud Reza Hashemi Rafsanjani, Majid Nouri, Saber Abbaszadeh, Saeid Heidari-Soureshjani, Karamali Kasiri, Ghorbanali Rahimian

    Background: Clostridium difficile is an opportunistic infection that can lead to antibi-otic-associated diarrhea and toxic megacolon. Objective: This systematic review study aimed to investigate polyphenols' antibacterial and anti-toxin properties and their effects on reducing complications related to C. difficile Infections (CDI). Methods: This systematic review was conducted following the PRISMA guideline 2020. Multiple databases, including Web of Science, PubMed, Cochrane Library, EMBASE, and Scopus, were searched thoroughly for existing literature. After considering the inclusion and exclusion criteria for the review, 18 articles were included. Data were collected and registered into an Excel file for further investigations and conclusions. Results: Polyphenols by reducing Reactive Oxygen Species (ROS) levels, increasing inflammatory factor Interleukin 10 (IL-10), reducing Nuclear Factor kappa B (NF-κB) and Tumour Necrosis Fac-tor-α (TNF-α), IL-6, IL-1α, IL-1β, Granulocyte Colony-stimulating Factor (G-CSF), and Monocyte Chemoattractant Protein-1 (MCP-1) and Macrophage Inflammatory Protein-1 alpha (MIP-1α) lev-els, and regulating the expression of Bcl-2 and Bax, make the growth and replication conditions of C. difficile more difficult and prevent it from producing toxins. Furthermore, polyphenols can ex-hibit prebiotic properties, promoting the growth of beneficial Bifidobacterium and Lactobacillus species and consequently regulating gut microbiota, exerting antimicrobial activities against C. dif-ficile. They also induce their beneficial effects by inhibiting the production of C. difficile TcdA and TcdB. Conclusion: Polyphenols have been reported to inhibit C. difficile growth and toxin production by several mechanisms in preclinical studies. However, more clinical studies are needed to investigate their safety in humans.


  • A Systematic Review and Meta-Analysis of the Effects of Statin Therapy on Heart Transplantation

    by Hossein Mardani-Nafchi, Seyed Mahmoud Reza Hashemi Rafsanjani, Saeid Heidari-Soureshjani, Saber Abbaszadeh, Babak Gholamine, Nasrollah Naghdi

    Background: Most of the mortality after Heart Transplantation (HT) is attributed to severe cardiac allograft vasculopathy (CAV) and rejection. Objectives: This meta-analysis aimed to investigate the effects of postoperative statin therapy on outcomes (mortality, rejection, and CAV in HT patients). Methods: This systematic review and meta-analysis was performed on publications between 1980 and October 2023 in Web of Science, Scopus, PubMed, Cochrane, Science Direct, Google Scholar, and Embase databases. Heterogeneity was assessed using Chi-square, I2, and forest plots. Publication bias was evaluated using Begg's and Egger's tests. Analyses were performed in Stata 15 with significance at p < 0.05. Results: This meta-analysis included 17 studies comprising 4,627 participants and conducted between 1995 to 2021. Compared to non-users, the odds of mortality were lower among statin users (OR= 0.49, 95% CI: 0.32–0.75, p < 0.001). The odds of CAV were also reduced with statin use (OR= 0.71, 95% CI: 0.53–0.96, p = 0.027). The odds of rejection were not significantly different (OR= 0.69, 95% CI: 0.41–1.15, p = 0.152). However, rejection odds were lower with statins in RCTs (OR= 0.42, 95% CI: 0.21–0.82, p = 0.012) but not in case-control studies (OR= 0.87, 95% CI: 0.49-1.52, p = 0.615). No publication bias was observed with Begg's test, but Egger's test showed possible bias. Conclusion: This meta-analysis found postoperative statin use associated with lower mortality and CAV, but not overall rejection, though RCT subgroup analysis showed decreased rejection with statins. Statin therapy may improve prognosis in HT patients.


  • Open Access

    The Antibiotic Susceptibility of Brucella spp. Isolated from Human Samples: A Systematic Review and Meta-Analysis

    by Mohammad Darvishi, Mohamad Reza Nazer, Seyed Mahmoudreza Hashemi Rafsanjani, Majid Nouri, Saeed Soleiman-Meigooni

    Background and Aim: Effective brucellosis treatment necessitates antibiotics that can penetrate macrophages. This study systematic review and meta-analysis aimed at assessing the antibiotic susceptibility profile of Brucella spp. isolated from humans, addressing this critical gap in understanding Brucella infections and their treatment. Materials and Methods: Two authors conducted a systematic search across PubMed, ...